Bionano Genomics Inc (BNGO)
0.2824
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
0.285
0.00 (0.00%)
After-Hours: 20:00
Bionano Genomics Total Liabilities (Quarterly): 49.03M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 49.03M |
| March 31, 2024 | 75.22M |
| December 31, 2023 | 118.25M |
| September 30, 2023 | 62.90M |
| June 30, 2023 | 56.62M |
| March 31, 2023 | 60.66M |
| December 31, 2022 | 58.10M |
| September 30, 2022 | 41.96M |
| June 30, 2022 | 36.82M |
| March 31, 2022 | 37.03M |
| December 31, 2021 | 39.98M |
| September 30, 2021 | 18.09M |
| June 30, 2021 | 10.94M |
| March 31, 2021 | 22.14M |
| Date | Value |
|---|---|
| December 31, 2020 | 25.37M |
| September 30, 2020 | 26.72M |
| June 30, 2020 | 21.37M |
| March 31, 2020 | 23.32M |
| December 31, 2019 | 26.59M |
| September 30, 2019 | 26.59M |
| June 30, 2019 | 26.56M |
| March 31, 2019 | 23.68M |
| December 31, 2018 | 14.67M |
| September 30, 2018 | 15.43M |
| June 30, 2018 | 75.37M |
| March 31, 2018 | 70.48M |
| December 31, 2017 | 60.37M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
10.94M
Minimum
Jun 2021
118.25M
Maximum
Dec 2023
42.69M
Average
37.03M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| Revvity Inc | 5.555B |
| Bruker Corp | 4.078B |
| Azenta Inc | 332.90M |
| Harvard Bioscience Inc | 61.66M |
| Akoya Biosciences Inc | 121.50M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 129.36M |
| Shareholders Equity (Quarterly) | 80.34M |
| Debt to Equity Ratio | 0.241 |
| Current Ratio | 1.629 |
| Net Debt Paydown Yield | -8.07% |